Tech Company Financing Transactions

CeNeRx BioPharma Funding Round

Aisling Capital, L Capital Partners and Pappas Ventures participated in a $9 million Series C capital raise for CeNeRx BioPharma. The financing round was announced on 6/16/2009.

Transaction Overview

Company Name
Announced On
6/16/2009
Transaction Type
Debt
Venture Equity
Amount
$9,000,000
Round
Series C
Investors

Aisling Capital (Steven Elms)

L Capital Partners (Ting Pau Oei)

Pappas Ventures (Arthur Pappas)

Proceeds Purpose
CeNeRx plans to use the proceeds to advance its pipeline of promising clinical and preclinical stage compounds for mood disorders, neurodegenerative conditions, and pain and spasticity.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
270 Cornerstone Dr. 103
Cary, NC 27519
USA
Email Address
Overview
CeNeRx (SEN-er-ex) is a privately held clinical stage company developing and commercializinginnovative and improved treatments for diseases of the central nervous system.
Profile
CeNeRx BioPharma LinkedIn Company Profile
Social Media
CeNeRx BioPharma Company Twitter Account
Company News
CeNeRx BioPharma News
Facebook
CeNeRx BioPharma on Facebook
YouTube
CeNeRx BioPharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Barry Brand
  Barry Brand LinkedIn Profile  Barry Brand Twitter Account  Barry Brand News  Barry Brand on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/16/2009: BNI Video venture capital transaction
Next: 6/16/2009: AdWhirl venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary